directly interacts with UT-A1 urea transporter: the role of caveolae/lipid rafts in UT-A1 regulation at the cell membrane. Am J Physiol Renal Physiol 296: F1514 -F1520, 2009. First published April 15, 2009 doi:10.1152/ajprenal.00068.2009The cell plasma membrane contains specialized microdomains called lipid rafts which contain high amounts of sphingolipids and cholesterol. Lipid rafts are involved in a number of membrane protein functions. The urea transporter UT-A1, located in the kidney inner medullary collecting duct (IMCD), is important for urine concentrating ability. In this study, we investigated the possible role of lipid rafts in UT-A1 membrane regulation. Using sucrose gradient cell fractionation, we demonstrated that UT-A1 is concentrated in the caveolaerich fraction both in stably expressing UT-A1 HEK293 cells and in freshly isolated kidney IMCD suspensions. In these gradients, UT-A1 at the cell plasma membrane is codistributed with caveolin-1, a major component of caveolae. The colocalization of UT-A1 in lipid rafts/ caveolae was further confirmed in isolated caveolae from UT-A1-HEK293 cells. The direct association of UT-A1 and caveolin-1 was identified by immunoprecipitation and GST pull-down assay. Examination of internalized UT-A1 in pEGFP-UT-A1 transfected HEK293 cells fluorescent overlap with labeled cholera toxin subunit B, a marker of the caveolae-mediated endocytosis pathway. Disruption of lipid rafts by methyl-␤-cyclodextrin or knocking down caveolin-1 by small-interference RNA resulted in UT-A1 cell membrane accumulation. Functionally, overexpression of caveolin-1 in oocytes decreased UT-A1 urea transport activity and UT-A1 cell surface expression. Our results indicate that lipid rafts/caveolae participate in UT-A1 membrane regulation and this effect is mediated via a direct interaction of caveolin-1 with UT-A1.
UREA AND THE UREA TRANSPORTERS play important roles in developing the medullary osmolarity gradient in the kidney and, therefore, in the regulation of water balance and blood pressure. The major mechanism for urea reabsorption is facilitated transport by urea transporters (UT). At present, two mammalian UT genes have been reported, UT-A and UT-B. The UT-A family of UT currently consists of six protein isoforms, plus three variants that differ in the 3Ј untranslated region. Four mammalian UT-A isoforms [UT-A1, A2, A3, and A4 (A4 only at mRNA level)] have been identified in kidney medulla (10, 25) . UT-A1 is the largest form. The others are structurally truncated forms of UT-A1. UT-A1 is expressed in the apical membrane of epithelial cells in the inner medullary collecting duct (IMCD) and plays an important role in urea reabsorption and the development of the corticomedullary osmolarity gradient. A UT-A1/UT-A3 knockout mouse has an impaired ability to concentrate urine (7) . Immunoblotting studies of UT-A1 in normal rat renal inner medulla reveal a predominant protein band of 97 kDa and a less abundant protein band of 117 kDa; both bands represent glycosylated versions of a nonglycosylated 84-kDa UT-A1 protein (2) .
The regulation of UT-A1 is complicated and occurs in multiple steps at different levels, including gene transcription, protein expression, and posttranslational modification. In response to vasopressin stimulation, UT-A1 is rapidly phosphorylated and trafficked in the surface membrane (13, 35) . This regulation is achieved, in part, through a PKA-dependent phosphorylation of UT-A1 on Ser486 and Ser499 in the predicted intracellular loop (1) . Recently, protein ubiquitination has been identified as another important mechanism for regulating UT-A1 activity by controlling protein degradation (5, 27) . However, as a membrane protein, which must be present in the cell membrane to facilitate urea transport, the regulatory mechanism at the cell surface is virtually unexplored.
The cell plasma membrane is a phospholipid bilayer. Research advances in cell membrane structure reveal that the plasma membrane contains specialized microdomains, referred to as lipid rafts, floating in the membrane (16, 21) . The lipid raft is a highly ordered membrane structure enriched in cholesterol and sphingolipids. These domains are resistant to detergent solubilization (Triton X-100) at low temperature and have increased buoyancy compared with other membrane phospholipids (mainly phosphatidylcholine). This characteristic allows lipid raft purification by sucrose gradient ultracentrifugation. Membrane lipid rafts are heterogeneous and dynamic. They have been implicated in several important cellular functions, such as internalization of receptors and their ligands, endocytic cargo delivery, signal transduction, and cholesterol transport (14, 21, 30) .
The goal of this study was to investigate the role of lipid rafts in the regulation of UT-A1 urea transport, particularly in UT-A1 endocytosis. We employed discontinuous sucrose density gradient ultracentrifugation to isolate the lipid raft and determined that membrane UT-A1 is concentrated in the lipid raft fractions. The UT-A1 internalization via caveolae pathway was determined by endocytosis assay with fluorescently conjugated cholera toxin subunit B (CTB). Alteration of lipid raft components by RNA interference, methyl-␤-cyclodextrin (M␤CD) treatment, or overexpression of caveolin influences UT-A1 protein membrane expression and/or urea transport activity. Collectively, these findings suggest that lipid rafts/ caveolae participate in UT-A1 membrane regulation.
MATERIALS AND METHODS
Plasmid constructs. Human caveolin-1 cDNA was purchased from ATCC (MGC-13070) and the coding region was subcloned into pcDNA3 (Invitrogen), pGEX4T2 (Amersham Pharmacia), and pGH19 oocyte expression vector. Rat UT-A1 cDNA was cloned into pGH19 vector (pGH19-UT-A1) or into pEGFP-C1 (Clontech) inframe with GFP at the COOH tail to produce a GFP fusion protein with the NH2 terminal of UT-A1 (pEGFP-UT-A1). To create FLAGtagged UT-A1, triple FLAG (DYKDDDDK) sequences and a KpnI site were introduced into the first extracellular loop of UT-A1 between amino acids 268T and 269T by PCR and cloned into pcDNA3 vector (pcDNA3-FLAG-UT-A1). Human caveolin-1-specific siRNA expression vector (31) was kindly provided by Dr. Xie (Medical College of Ohio). To construct human dynamin siRNA expression vector, a specific sequence (GGACATGATCCTGCAGTTCAT) was selected and cloned into pSuppressor vector (IMGENEX, San Diego, CA) which contains the U6 promoter. A scrambled sequence (TCAGT-CACGTTAATGGTCGTT) was used as a negative control. All constructs were verified by DNA sequencing.
Kidney IMCD tubule suspension preparation. All animal protocols were approved by the Emory University Institutional Animal Care and Use Committee. To examine whether UT-A1 is associated with caveolae in vivo, rat kidney IMCD suspensions were prepared as described before (13) and used for lipid raft isolation. Briefly, IM tissues were dissected from Sprague-Dawley rats and minced in digestion buffer containing 540 U/ml hyaluronidase (Sigma), 2 mg/ml collagenase B (Sigma), and 0.5 mg/ml BSA. The tissues were incubated at 37°C with periodical agitation. After 30 min, 1 l/ml of DNAse was added for another 30 min, followed by four washes in saline buffer. Tubule suspension quality was assessed under a dissecting microscope and used for lipid raft isolation.
Lipid raft isolation. Lipid raft fractionation was performed using a slight modification of a previously described method (6) . UT-A1 HEK293 cells or freshly isolated IMCD suspension were lysed in 600 l of ice-cold 1% Triton X-100/TNEV buffer (10 mM Tris ⅐ HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 2 mM Na vanadate, and protease inhibitor cocktail) for 1 h on ice. Lysates were centrifuged at 10,000 rpm for 3 min at 4°C and 500-l supernatant was mixed with an equal volume of 80% sucrose in TNE (without Triton X-100) and transferred to 13 ϫ 23-mm Beckman centrifuge tube. Three milliliters of 35% sucrose in TNE were layered carefully on the top of the mixture followed by another 1-ml layer of 5% sucrose. The sucrose gradient was then centrifuged in a SW 50.1 rotor (Beckman) at 34,000 rpm (110,000 g) for 20 h at 4°C. Fractions were collected from the top to bottom of the tube and analyzed by Western blot for UT-A1 and protein markers.
Cell culture and transfection. HEK293 cells (Stratagene) and permanent cell lines of 293 cells expressing UT-A1 (UT-A1-293) were cultured in DMEM supplemented with 10% fetal calf serum at 37°C in 5% CO2. Cells were grown to 80% confluence in six-well plates and transfected with 2 g/well plasmids. Transfection was carried out using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. After 48-h incubation, transfected cells were collected and used for biotinylation, immunoblotting, or immunofluorescence studies.
Caveolae isolation. Caveolae were isolated from UT-A1-HEK293 cells by using a caveolae isolation kit (Sigma). UT-A1-HEK293 cells grown in two 10-cm dishes were collected and lysed with lysis buffer containing 1% Triton X-100. The lysates were centrifuged at 10,000 g for 15 min. Detergent-resistant membrane fractions were isolated on OptiPrep Density Gradient Medium (0, 20, 25, 30, and 35%). Caveolae were collected from caveolin-1-enriched fractions.
Cell surface biotinylation assay. As a measure of UT-A1 membrane association, we used a biotinylation assay. UT-A1-HEK293 cells transfected with siRNA pSuppressor plasmids for 48 h were processed for cell biotinylation as described before (4). Briefly, after treatment, the cells were placed on ice and washed with ice-cold PBS twice. The cells were incubated with ice-cold biotinylation buffer [10 mM Tris ⅐ HCl (pH 7.5), 2 mM CaCl2, 150 mM NaCl, 1.0 mg/ml Sulfo-NHS-Biotin] for 40 min at 4°C. Excess biotin was quenched with 0.1 M lysine. Cells were washed with PBS again and lysed in RIPA buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.5% deoxycholate, and 0.1% SDS) containing a protease inhibitor cocktail (Sigma). Protein concentration was determined by BCA protein assay according to the manufacturer's instructions (Pierce). Equal amounts of proteins were added to 20 l of streptavidin beads overnight. The biotin-conjugated proteins were eluted and processed for Western blot with UT-A1 antibody.
GST pull-down assay. To prepare GST-caveolin fusion protein, pGEX-4T2-caveolin was transfected into BL21 cells (Stratagene). Cells were grown at 30°C overnight and induced with 1 mM isopropyl thio-beta-D-galactopyranoside (IPTG; Calbiochem) for 4 h. The bacterial pellet was resuspended and sonicated in harvest buffer (10 mM HEPES, 50 mM NaCl, 1 mM benzamidine, 5 mM EDTA, and a cocktail of protease inhibitors). The lysates were centrifuged for 30 min at 15,000 rpm. The supernatants were collected and the GST fusion proteins were purified by incubation with Glutathione Sepharose 4B beads (Amersham Bioscience) at 4°C overnight with gentle rotation. The beads were washed with harvest buffer. For GST pull-downs, rat kidney IM tissues were lysed in RIPA buffer; the cleared total lysates were first preincubated with GST beads alone for 2 h at 4°C with constant rotation. After centrifugation, the supernatant was collected and processed for GST pull-down assay incubating with GST or GST-caveolin-1 at 4°C overnight. After being washed, the proteins were eluted with Laemmli buffer and subjected to Western blot analysis.
Immunoprecipitation and Western blot. For immunoprecipitations, cell lysates or isolated caveolae were lysed in RIPA buffer containing protease inhibitors. Protein content was determined by BCA (Pierce). The lysates were incubated with UT-A1 antibody overnight, and then protein-A beads for 2 h at 4°C with rotation. Beads were collected by washing and centrifuging with the lysis buffer. Proteins were eluted by Laemmli sample buffer and subjected to SDS-PAGE. Separated proteins were transferred to PVDF membranes. The membranes were incubated with primary antibody, followed by anti-mouse or antirabbit horseradish peroxidase-conjugated secondary antibodies (Amersham) and detected with enhanced chemiluminescence. The following primary antibodies were used: anti-UT-A1 (18), anti-AQP2 (11), anti-caveolin-1 (BD Bioscience), anti-dynamin-2 (Santa Cruz Biotechnology), and anti-2 (kindly provided by Dr. J. Bonifacino, National Institute of Child Health and Human Development/National Institutes of Health).
Immunofluorescence. For the detection of colocalization of UT-A1 and lipid rafts, HEK293 cells were grown in six-well plates and transiently transfected with pEGFP-UT-A1 overnight. Cells were then transferred to four-chamber slides (BD Bioscience) and incubated for another 48 h. Cells were fixed with 4% paraformaldehyde for 10 min. After PBS washing, cells were stained with Alexa-594-conjugated CTB (Molecular Probes) for 30 min at room temperature. After PBS washing, cells were mounted in Vectorshield medium (Vector Laboratories) and examined by confocal microscopy.
Internalization study. To determine the manner in which UT-A1 protein is internalized, cells were seeded in six-well plates and transiently transfected with the pcDNA3-FLAG-UT-A1 plasmid overnight and transferred to four-well chamber slides for a further 48-h incubation. Cells were placed on ice, washed with ice-cold PBS three times, and incubated with mouse anti-FLAG antibody (Sigma; 1:100 dilution) and Alexa-594-conjugated CTB (Molecular Probes; 1:500 dilution) on ice for 45 min. After being washed with ice-cold PBS, the cells were incubated with prewarmed 10% FCS complete medium at 37°C for 5 min to induce endocytosis. Endocytosis was stopped by washing with ice-cold PBS on ice. The remaining antibody and CTB on the cell surface were stripped by 0.2 M glycine (pH 2.2) treatment, 2 s twice. Cells were then fixed with cold acetone/methanol (1:1) for 10 min and permeabilized with 0.1% Triton X-100 for 5 min. Cells were incubated with 1:400 FITC-conjugated goat anti-mouse IgG (Sigma) for 1 h. Nuclei were counterstained with TOPRO-3 (Molecular Probes). Cells were mounted in Vectorshield medium and the images were captured by confocal microscopy at identical microscopic settings.
Oocyte experiment. For examination of urea transporter activity, a Xenopus laevis oocyte system was used. X. laevis oocytes were harvested, defolliculated, and maintained as detailed by Romero et al. (24) . Capped cRNAs were synthesized with T7 polymerase using the mMESSAGE mMACHINE T7 Ultra Kit (Ambion). Two nanograms of UT-A1 and/or 2 ng of caveolin-1 cRNAs in total volume of 23 nl water were injected into each oocyte. Secreted alkaline phosphatase (SEAP) was used as an internal marker to monitor microinjection and protein translation in cells (29) . All cells including water injection included 2 ng of SEAP cRNA. Three days later, oocytes were selected by phosphatase activity for protein expression and urea transport functional measurements. SEAP activity in the medium of each individual cultured oocyte was determined using a standard colorimetric assay.
For the urea uptake assay, oocytes (5-6 per time point) were preincubated with uptake solution (in mM: 200 mannitol, 2 KCl, 1 MgCl 2, 1 CaCl2, 10 HEPES buffer, 5 Tris, pH 7.4) for 1 h. Cells were then incubated at different time points with 1 Ci [ 14 C]urea/ml and 1 mM cold urea in uptake solution. They were washed four times with ice-cold uptake solution containing 1 mM urea. Each individual cell was dissolved in 10% SDS followed by scintillation counting.
Oocyte cell biotinylation was performed with some modification according to Harris et al. (8) . Oocytes (20/group) were preincubated with ND96 for 1 h at 4°C. Cells were then labeled with biotin in a biotinylation buffer containing 10 mM triethanolamine, 150 mM NaCl, 2 mM CaCl 2, and 1.5 mg/ml EZ-link sulfo-NHS-SS-Biotin Fig. 2 . UT-A1 associates with caveolin and colocalizes with lipid rafts. A: caveolae were isolated from UT-A1-HEK293 cells and blotted with UT-A1 antibody. UT-A1 was detected in the isolated caveolae. B: UT-A1 was immunoprecipitated from the total lysate and the isolated caveolae. The immunoprecipites were blotted for caveolin-1. *Unknown nonspecific band. C: GST pull-down assay. GST-caveolin-1 was incubated with rat IM tissue lysates (2 rats). The pulled-down samples were analyzed with UT-A1 antibody. D: HEK293 cells were transfected with pEGFP-UT-A1 for 48 h. Cells were fixed in 4% paraformaldehyde, incubated with Alexa-594-conjugated cholera toxin B (CTB), and visualized with a confocal microscope. A, B, and D were repeated twice. C was repeated 3 times.
(Pierce) for 30 min. Excess biotin reagent was quenched by 0.1 M glycine in OR3 medium for 10 min. After being washed, the cells were lysed in 700 l of lysis buffer containing 1% Triton X-100, 500 mM NaCl, 5 mM EDTA, 50 mM Tris ⅐ HCl, and protease inhibitor cocktail (Sigma). The lysates were centrifuged for 10 min at 10,000 rpm. Fifty microliters of supernatant were saved as total protein for Western blotting and 550 l of supernatant were added to 20 l of immunopure immobilized streptavidin beads (Pierce) for precipitating the membrane biotin-labeled proteins. After overnight incubation at 4°C, the beads were washed and the biotin-conjugated proteins were eluted and processed for Western blot with UT-A1 antibody.
Oocyte M␤CD treatment. M␤CD was used to deplete plasma membrane cholesterol in X. laevis oocytes (32) . After 3 days of cRNA microinjection, oocytes were washed with uptake solution and incubated with 10 mM M␤CD (Sigma) in the same solution for 2 h. Cells were then used for urea uptake assay and protein expression as described above.
Statistical analysis. Urea flux data are expressed as means Ϯ SD. Statistical analysis of the data was performed by one-way ANOVA followed by Tukey HSD tests. Differences were considered as significant at *P Ͻ 0.05 or **P Ͻ 0.01.
RESULTS

Cell membrane UT-A1 is concentrated in lipid raft pools of the cell membrane and codistributed with caveolin-1.
To characterize UT-A1 distribution in the cell membrane fraction, we used discontinuous sucrose density gradient ultracentrifugation to fractionate lipid raft and nonraft membrane fractions of 1% Triton X-100 lysates from UT-A1 HEK293 cell. Aliquots of each fraction were analyzed for UT-A1 and protein marker expression. The majority of UT-A1 was present in fractions 2-4 at the 5 and 35% sucrose interface, the lipid raft fraction (Fig. 1A) . Caveolin-1 was used as a marker for lipid raft/ detergent-resistant membrane-containing fractions. The nonlipid raft fraction was verified by the clathrin adaptor protein 2, which was localized in the high-density nonlipid raft fractions (fractions 11-13) . UT-A1 expression in the membrane fraction is codistributed with caveolin-1 (Fig. 1A) .
To explore whether the specific UT-A1 distribution at the cell surface has physiological significance, rat kidney IMCD suspensions were prepared and processed for lipid raft fractionation. As shown in Fig. 1B , UT-A1 was mainly located in lipid raft fractions (fractions 3-4), identical to the result found in UT-A1 HEK293 cells. AQP2 is another important transporter protein expressed in IMCD epithelial cells. We also examined AQP2 plasma membrane distribution in IMCD. The same membrane that was probed for UT-A1 was stripped and reprobed with AQP2 antibody. In contrast to UT-A1, which is mainly distributed in the lipid raft fraction, AQP2 is not distributed in the specific subdomains of plasma membrane. AQP2 is nearly evenly distributed in Triton X-100-insoluble, cholesterol-rich membrane rafts (lanes 2 and 3) and in Tritonsoluble nonraft membranes (lanes 10, 11, 12, and 13) .
UT-A1 interacts with caveolin-1 and colocalizes with lipid rafts. To investigate whether localization of UT-A1 in caveolin-enriched microdomains is due to a physical association between caveolin-1 and UT-A1, caveolae were isolated from UT-A1-HEK293 cells. UT-A1 was identified in the isolated caveolae ( Fig. 2A) . The direct interaction of UT-A1 and caveolin-1 in caveolae was identified by immunoprecipitation with UT-A1 antibody and blotting with caveolin antibody (Fig. 2B) . This result was further confirmed by GST pull-down assay. UT-A1 was pulled down by GST-caveolin-1 from IM tissue lysates (Fig. 2C) .
CTB, which binds to a GM1 ganglioside associated with lipid rafts, was used as a marker for lipid rafts (19) . We used Alexa-594-conjugated CTB to label lipid rafts and observed the colocalization of EGFP-UT-A1 with lipid rafts in HEK293 cells by confocal microscopy. Figure 2D shows that at the plasma membrane some EGFP-UT-A1 (green color) colocalized with lipid rafts (red color).
UT-A1 endocytosis is through caveolae/lipid raft pathway. To determine whether caveolae/lipid rafts are involved in UT-A1 internalization, we introduced a FLAG tag into the first extracellular loop of UT-A1 (Fig. 3A) and transfected it into HEK293 cells. Cell surface UT-A1 was exposed to anti-FLAG antibody in live HEK293 cells on ice and UT-A1 internalization was carried out by rewarming cells at 37°C. The internalized UT-A1 was visualized by incubating with FITC-anti-mouse secondary antibody and internalized caveolae were labeled by Alexa-594-conjugated CTB. Figure 3B shows the partially overlapped yellow color in the cytosol indicating UT-A1 endocytosis enters CTBpositive subcellular compartments.
Knock down of caveolin-1 increased UT-A1 cell surface expression. Caveolin is the major component of the caveolae and is directly associated with UT-A1. To study the role of caveolin-1 on the UT-A1 cell membrane expression, a caveolin-1 siRNA expressing vector was transiently transfected into UT-A1-HEK293 cells. The level of caveolin-1 in cells transfected with caveolin-1-specific siRNA was reduced. Dynamin is known to be involved in both caveolae and clathrin-coated pit (CCP)-mediated endocytosis (12) . Transfection with caveolin-1-or dynamin-specific siRNA significantly increased UT-A1 accumulation at the plasma membrane (Fig. 4) .
Disruption of lipid rafts increased UT-A1 plasma membrane expression and urea transport activity. Next, we investigated whether lipid raft disruption could directly affect UT-A1 membrane expression and urea transport activity in X. laevis oocyte system. UT-A1 cRNA was prepared and microinjected into X. laevis oocytes. Cell membrane cholesterol was depleted with M␤CD (32). Cell surface UT-A1 was examined by biotinylation. Figure 5 shows depletion of cholesterol by M␤CD pretreatment for 2 h increased membrane UT-A1 expression and urea transport activity.
Overexpression of caveolin-1 decreased UT-A1 urea transport activity. Finally, the direct effect of caveolin-1 on UT-A1 urea transport activity was examined in X. laevis oocytes. UT-A1 cRNA was injected alone or in combination with caveolin-1 or dynamin cRNAs into oocytes. Urea transport activity was measured by [ 14 C]urea flux and the total and cell surface UT-A1 was detected by Western blot and biotinylation. Coinjection of cRNA for caveolin or dynamin caused a decrease of UT-A1 urea transport activity. The decreased urea transport activity could be due to increased UT-A1 internalization since the cell surface UT-A1 was significantly reduced as judged by decreased biotinylated UT-A1 (Fig. 6 ).
DISCUSSION
In this study, we report that the UT-A1 urea transporter is associated with caveolae/lipid rafts in UT-A1-HEK293 cells and in native IMCD suspensions (Fig. 1) , as determined by sucrose gradient fractionation and confocal microscopy. Such membrane microdomain targeting of UT-A1 is due to a direct interaction with caveolin-1. The specific localization of UT-A1 at the cell membrane suggests caveolae/lipid rafts have an important role in regulating UT-A1 activity. We further found that the internalized UT-A1 colocalized with CTB, indicating that UT-A1 undergoes caveolin-dependent endocytosis. Knockdown of caveolin by siRNA leads to UT-A1 accumulation in the plasma membrane. UT-A1 endocytosis is significantly inhibited by agents that deplete plasma membrane cholesterol. Overexpression of caveolin reduces UT-A1 urea transport activity.
Many proteins found in caveolar microdomains are directly associated with caveolin. The caveolin protein is essential for the formation of caveolae. Caveolin has been shown to bind the two primary components of lipid rafts, cholesterol and sphingolipids, both in vitro and in vivo (30) . There are three caveolin isoforms. Caveolin-1 is the most ubiquitously expressed. It is found in the kidney, lung, heart, and brain. Caveolin-2 facili- tates but is not essential for caveolae formation. Caveolin-3 is specific to muscle (14, 21) . Besides serving as the structural protein of caveolae, caveolin protein acting as a scaffolding protein plays an important role in recruiting numerous proteins into lipid rafts. These caveolin-binding proteins include EGF receptor, insulin receptor, TGF-␤ receptor, COX-2, PKA, and PKC-␣ (17, 23) . In our study, we found that UT-A1 urea transporter concentrated in caveolae is through interaction with caveolin-1 protein. There is a second group of proteins which do not directly bind to caveolin protein but can reside in caveolae. The best-characterized caveolae-associated proteins such as HRas, Src family tyrosine kinases, heterotrimeric G protein ␣ subunits, and endothelial nitric oxide synthase have one or several posttranslational modifications with myristoyl, palmitoyl, farnesyl, or geranylgeranyl lipophilic groups (17, 34) .
The finding that UT-A1 is highly concentrated in lipid rafts relative to other parts of the membrane raises the question of why it resides in them and what is the consequence to UT-A1. It is most likely that UT-A1 moves into lipid rafts and is internalized via a caveolae-mediated endocytic pathway, as seen in some membrane proteins like interleukin-2 receptor (15), IgE receptor (6), and calcium channel TRPV5 (3). Internalization of membrane proteins involves balancing membrane protein abundance at the cell surface, activity regulation, recycling, and degradation (14, 17, 23, 30) . Different proteins follow different internalization routes. ENaC (26) , AQP2 (28) , transferrin receptor (6) , and ROMK1 (9) endocytosis have been reported to be mediated by CCP, which, in general, are not lipid raft associated. Our results in Fig. 3B clearly show that some endocytic UT-A1 in cells accompanied internalized CTB, suggesting that the UT-A1 endocytic mechanism occurs via lipid raft-mediated endocytosis, which differs significantly from those processes previously identified for ENaC (26) and AQP2 (28) . However, we cannot exclude the possible involvement of other endocytic pathways such as CCP-mediated endocytosis in UT-A1 internalization, since some of the UT-A1 (Fig. 3B, in green) did not overlap with CTB (red).
Interestingly, unlike UT-A1, which is mainly distributed in the lipid raft fraction, we found that half of AQP2 is in Triton-soluble nonraft membranes. Our result is consistent with the recent report of Knepper and colleagues (33) . A large amount of AQP2 located in nonlipid pools could be the answer to why AQP2 endocytosis is through clathrin-mediated pathway as reported by Sun et al. (28) .
Traditionally, lipid rafts/caveolae have been associated with endocytosis. More recently, emerging evidence shows that Fig. 5 . Lipid raft disruption by methyl-␤-cyclodextrin (M␤CD) increases UT-A1 expression at the cell surface. Three days after cRNA microinjection, the oocytes were incubated with 5 mM M␤CD for 2 h at room temperature and then processed for [ 14 C]urea uptake assay (n ϭ 5ϳ6 oocytes/time point; A) or cell surface UT-A1 expression by biotinylation (B). This experiment was repeated 2 additional times with similar results. **P Ͻ 0.01. Fig. 6 . Overexpression of caveolin-1 reduces UT-A1 cell surface protein expression and urea transport activity. Oocytes were coinjected with cRNAs encoding UT-A1 (2 ng/cell), plus dynamin or caveolin-1 (5 ng/cell) for 3 days. A: urea transport activity was measured by [ 14 C]urea flux (n ϭ 5ϳ6 oocytes/ time point). *P Ͻ 0.05; **P Ͻ 0.01. B: cell surface UT-A1 protein expression was measured by biotinylation. These results were reproduced 2 additional times. lipid rafts have also been involved in a variety of cellular functions, including protein membrane targeting, protein activation, signal transduction, and lipid transport (14, 17, 21, 23) . In this study, for the first time, we identified UT-A1 targeting in the lipid raft fraction in the cell membrane. Whether the UT-A1 in lipid rafts simply represents the inactive form or whether UT-A1 is sequestered in lipid rafts is not clear. We also do not know whether UT-A1 activation needs to be translocated into the nonlipid raft fraction as seen for EGF and ␤2 adrenergic receptors, which move away from lipid rafts following receptor activation (20, 22) . Indeed, we found that cholesterol depletion by M␤CD increases urea transport activity. Is this due to UT-A1 release from lipid rafts? Whether lipid rafts modulate UT-A1 function other than through endocytosis is currently under investigation.
In conclusion, cell membrane UT-A1 is specifically compartmentalized in the lipid raft subdomain. This unique distribution is due to its direct association with caveolin-1 protein.
Lipid rafts/caveolae participate in UT-A1 membrane regulation. Alteration of UT-A1 internalization via lipid rafts/caveolae endocytic pathway could be one of the mechanisms for UT-A1 regulation in response to extra stimuli.
